Anti-helicobacter pylori pharmaceutical composition and application thereof

The invention discloses an anti-helicobacter pylori pharmaceutical composition and application thereof, relates to the technical field of traditional Chinese medicines, and solves the problems that when antibiotics are used for treating helicobacter pylori at present, the drug resistance problem of the antibiotics is increasingly serious, and gastrointestinal flora disorder is easily caused. Calculated according to the total volume of 1 ml, the lactic acid bacteria accounts for 10% 10 < 8 > CFU/mL, the coptis chinensis accounts for 2-4 mg/ml, and the salvia miltiorrhiza accounts for 4-8 mg/ml. According to the pharmaceutical composition disclosed by the invention, the activity of urease, the formation of a biological membrane and the movement ability are inhibited in a multi-component, multi-target and multi-channel manner, so that the effect of resisting Hp is further exerted, and an in-vitro pharmacodynamic experiment basis before clinical research is provided for the development of the pharmaceutical compo